1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Charles Ryan: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer BEZ235, Prednisone, Abiraterone acetate - Castrate-resistant Prostate Cancer | Phase 1 / Phase 2 | Terminated | Charles Ryan | 6 | 2013-01-31 | 2018-03-27 |
Abiraterone Acetate (1) · Prednisone (1) · dactolisib (1)
United States (1)